HealthWise KnowledgeBase
Radiation Therapy With Monoclonal Antibodies
How Well It Works
Ibritumomab and tositumomab are effective treatments for nonaggressive, low-grade NHL that has relapsed or not responded to other treatment.
| By: | Reference Healthwise Staff | Last Revised: March 29, 2012 |
| Medical Review: | Reference Anne C. Poinier, MD - Internal Medicine
Reference Douglas A. Stewart, MD - Medical Oncology |
|
© 1995-2011, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.
